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ABSTRACT
￿
In previous work we have examined the nature of converting enzymes for proin-
sulin, proglucagon, and prosomatostatin-I (PSS-I) in Secretory granules isolated from anglerfish
islets. The purpose of the present study was to extend the examination of precursorconversion
to islet microsomes and to compare prohormone processing, including that of PSS-I and
prosomatostatin-II (PSS-II), in islet Secretory granules and microsomes . Microsomes (rough
endoplasmic reticulum [RER] and Golgi complex) and Secretory granules were prepared from
anglerfish islets by differential and discontinuous density-gradient centrifugation . Microsomes
were further fractionated into Golgi- and RER-enriched subtractions . Lysed Secretory granule
or microsome preparations were incubated in the presence of a mixture of radioactively
labeled islet prohormones. Extracts of products generated were subjected to analysis by gel
filtration and high-pressure liquid chromatography. Accuracy of product cleavage was moni-
tored by comparing high-pressure liquid chromatography retention times from the radiola-
beled in vitro conversion products with the retention times of labeled products from tissue
extracts.
All converting activity in microsomes was found to be similar to that in granules in that it
had a pH optimum near pH 5 and was inhibited by p-chloromercuribenzoate. No significant
differences in the converting activity of Golgi complex- and RER-enriched subtractions of
microsomes was observed . The proinsulin, proglucagon, and PSS-II converting-enzymes,
which were found in islet Secretory granules, were also present and membrane-associated in
islet microsomes. However, converting activity for PSS-I was displayed only in Secretory
granules. This suggests that two or more separate enzymes are involved in processing PSS-I
and PSS-II, and that these enzymes have either differential distribution or differential activity
in RER/Golgi complexand Secretory granules. The demonstration of converting enzyme activity
in islet microsomes supports the proposal that these enzymes may be synthesized at the RER
and are internalized along with the prohormones.
Although there is a large body of evidence that demonstrates
that most peptide hormones destined for export from their
cells of origin are synthesized initially as preprohormones,
very little is known about the subcellular distribution and
characteristics of the enzymes involved in co- and posttrans-
lational proteolytic processing ofthese precursors. In previous
studies performed in this laboratory, thecharacteristics of the
converting activities of proinsulin, proglucagon, and proso-
matostatin-I foundin Secretorygranules from anglerfish (AF)'
pancreatic islets were examined. It was found that one or
I Abbreviations used in this paper: AF, anglerfish; HPLC, high-pres-
sure liquid chromatography (reverse phase); PSS-1 and II, anglerfish
prosomatostatin-I and II; RER, rough endoplasmic reticulum; RT,
retention time; SS-14, anglerfish/synthetic somatostatin-14 (cleavage
product of PSS-I); SS-28, anglerfish/somatostatin-28 (cleavage prod-
uct of PSS-11).
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these prohormones had unique characteristics that differen-
tiate them from other intracellular proteases. The enzyme(s)
is a cysteine proteinase, has a pH optimum near 5, cleaves as
an endoprotease at basic amino acid residues, may require
the presence of segments of the prohormone in addition to
the dibasic residues at cleavage sites for substrate recognition
and/or binding, and is (secretory granule) membrane associ-
ated (1-3). The enzyme(s) has some of the characteristics of
cathepsin B but differs from cathepsin B in that it is not
inhibited by N-p-tosyl-L-lysine-chloromethyl ketone HCl and
has a more restricted substrate specificity. Converting en-
zymes cleave more selectively than cathepsin B, usually at
sites where pairs of basic amino acids are found in the
polypeptide sequence. However, not all basic pairs that are
found in prohormones serve as cleavage sites.
It would be consistent with the data presently available to
hypothesize that the acid cysteine proteinase found in secre-
tory granules from AF islets performs the initial "trypsinlike"
cleavage, whichwasoriginally proposed as the first processing
step necessary in proinsulin conversion (4-9), andis necessary
in the processing of most other prohormones. Recently, pro-
hormone-converting enzymes with characteristics very similar
to the acid cysteine proteinase in AF islet granules have been
identified in secretory granules from rat pituitary anterior lobe
(10), neurointermediate lobe (11), and from bovine pituitary
posterior lobe (12).
In addition to proinsulin and proglucagon(s), at least two
different forms of somatostatin-like peptide are produced in
AF islets. These include prosomatostatin-I (PSS-1), the pre-
cursor of anglerfish/synthetic somatostatin-14 (SS-14), and a
second precursor (PSS-I1), which contains at its COOH-ter-
minus [Tyr', Gly' °] SS-14 as a potential cleavage product.
However, even though an Arg-Lys pairis located immediately
NH2-terminal to Ala' of the COOH-terminal tetradecapep-
tide, [Tyr', Gly'°] SS-14 could not be detected in extracts of
AF islets (13, 14). Subsequently, a 28-residue peptide (AF SS-
28) that has [Tyr', Gly'°] SS-14 as its COOH-terminus was
found to be a primary cleavage product ofPSS-11 (manuscript
in preparation). The purpose of the present study was to
compare the converting activity(ies) of prohormones in mi-
crosomes with those in secretory granules and to examine the
differential processing of the two somatostatin precursors in
more detail. Experiments were designed to determine; (a)
whether the processing activities of proinsulin, proglucagon,
PSS-I, and PSS-II could be found in both islet microsomes
and secretory granules; (b) whether the processing activities
were membrane-associated or soluble in these fractions; and
(c) whether there was adifference in the relative contribution
of Golgi complex and rough endoplasmic reticulum (RER)
to overall converting activity of microsomes.
MATERIALS AND METHODS
Materials:
￿
L-['H]tryptophan (8 Ci/mmol) and L-['SS]cysteine (928 Ci/
mmol) were purchased from New England Nuclear, Boston, MA. L-['"C]-
isoleucine (300 mCi/mmol) was purchased from ICN Pharmaceuticals, Irvine,
CA. Bio-Gel P-2 (100-200 mesh), P-30 (50-100 mesh and 100-200 mesh), and
Protein Reagent Kit were obtained from Bio-Rad Laboratories, Rockville
Center, NY. Monofluor scintillation cocktail was purchased from National
Diagnostics, Inc., Somerville, NJ. High-pressure liquid chromatography
(HPLC) grade acetonitrile and 2-propanol were obtained from Fisher Scientific
Co., Atlanta, GA, and reagent grade trifluoroacetic acid used in the HPLC
solventswas purchased from Pierce Chemical Co., Rockford, IL. Cocarboxylase
(thiamine pyrophosphate), phosphorus standard, acid molybdate, and Fiske
and Subbarow reducer were obtained from Sigma Chemical Co., St. Louis,
MO. Synthetic SS-14 and [Tyr', Gly'°] SS-14 were the generous gifts of Dr.
Jean Rivier, Salk Institute, San Diego, CA.
Preparation of Microsomes and Secretory Granules:
￿
Frac-
tionation of decapsulated islet tissue was performed as previously described (2,
15) with all procedures being carried out at 4°C. For the present studies, the
two secretory granule fractions (granule diameter ranging [a] from 150 to 200
nm and [b] from 220 to 310 nm) were pooled, diluted in 0.25 M sucrose and
1 mM MgCl, and precipitated at 150,000 g for 30 min. The F-III band
(microsomes) was aspirated from the surface ofthe 1.4 M sucrose, transferred
to another centrifuge tube, and also precipitated at 150,000 gfor 30 min. As
previously determined, these fractions show very little contamination by lyso-
somal enzymes (2). For conversion assays, the microsome and granule pellets
were suspended separately in 100 mM sodium acetate-acetic acid, pH 5.2 and
the particulates were dispersedby using a hand-held Teflon pestle-glass homog-
enizer. Before incubation with labeled prohormones of M, 8,000-15,000 (see
below), the dispersed secretory granule and microsome suspensions were lysed
by six cycles of rapid freezing and thawing. For experiments designed to assess
the converting activity of the soluble and membranous components of micro-
somes or secretory granules independently, lysed microsomes or granule prep-
arations were subjected to centrifugation at 12,800 g for 10 min at 4°C in a
microcentrifuge. Supernatants were removed and saved; membranous precipi-
tates were washed in 100 mM sodium acetate-acetic acid, pH 5.2, and repre-
cipitated twice. The resulting pellet was suspended in 500 Al ofthe same buffer
andtransferred to a hand-held homogenizer to disperse the membranes. For
some experiments, membranes were washed with 1 M KCl to remove mem-
brane-associated proteins before performance of conversion assays. In these
instances membrane preparations were suspended and dispersed in 100 mM
sodium acetate-acetic acid, I M KCI, pH 5.2. After 30 minat 4°C, membranes
were precipitated by a 10-min centrifugation in the microcentrifuge and washed
twice with 100 mM sodium acetate buffer before final suspension for the
conversion assay. For experiments in which microsomes were to be incubated
at varying pH values, precipitates were suspended in 100 mM sodium acetate-
acetic acid or 100 mM sodium phosphate at the appropriatepH. Aliquots were
removed from all granule or microsome preparations to determine protein
content.
Preparation of Microsomal Subfractions: To prepare Golgi
complex- and RER-enriched subfractions of microsomes, centrifugation
through a discontinuous sucrose density gradient was performed. Precipitated
microsomes were suspended in 0.5 ml of0.25 Msucrose and 1 MM MgCl2 and
dispersed in a hand-held homogenizer. The original centrifuge tube and ho-
mogenizer were washed twice with an additional 0.5 ml of sucrose-MgCIZ. The
discontinuous gradient was formed in a 5-ml cellulose nitrate tube (Beckman
Instruments, Inc., Fullerton, CA)by sequentially layering over 0.5 ml of 2.0 M
sucrose, 0.7-ml aliquots of 1.5, 1 .4, 1.3, 1 .2, and 1 .1 Msucrose (all containing
1 mM MgCIZ). The dispersed microsome preparation was then layered above
the 1 .1 M sucrose band and the tube was filled with 0.25 M sucrose, 1 mM
MgCl2. Centrifugation was performed in an SW 50.1 rotor (Beckman Instru-
ments. Inc.) at 142,000 g for 2 h. After centrifugation, four clearly visible
particulate bands (1-2 mm wide) were observed at the interfaces between 1 .1-
1.2 M, 1 .2-1.3 M, 1 .3-1.4 M, and 1 .4-1 .5 M sucrose layers. Usually, a less
distinct particulate band was found at the 1 .5-2.0 M interface as well. These
bands were designated subfractions 1-5, respectively. All bands were removed
separately by aspiration, diluted in 0.25 M sucrose-I MM M9C12, and concen-
trated by centrifugation.
Preparation of Labeled Prohormones:
￿
Incubations of 75-100
mg of islet tissue were performed in the presence of50 j Ci ['H]tryptophan plus
either 10 pCi ['°C]isoleucine or 40 uCi ['sS]cysteine aspreviously described (1-
3). After a 5-h incubation with the labeled amino acids, the medium was
removed and the tissue homogenized in 1 .0 ml of 2 M acetic acid. Insoluble
material was removed by centrifugation and reextracted with 0.5 ml of 2 M
acetic acid. After centrifugation, the soluble components were pooled and
desalted on columns of Bio-Gel P-2 in 2 Macetic acid and lyophilized. Desalted
extracts were suspended in 2 Macetic acid and filtered in 2 M acetic acid on
1.6 x96-cm columnsofBio-Gel P-30 (55% 50-100 mesh, 45% 100-200 mesh).
Thepolypeptides ofM8,000-15,000 were recovered by pooling and lyophiliz-
ing the appropriate portions of the gel filtration eluates. This pool contains AF
proinsulin, proglucagon(s), and prosomatostatin(s) (1-3, 13, 14). Before incu-
bation with lysed microsome or secretory granule suspensions, the precursors
were suspended in 100 mM acetic acid and the pH was adjusted to 5.0 using 2
M sodium acetate. Aliquots were taken to determine protein content.
In Vitro Conversion Assays:
￿
Aliquots of lysed microsome or secre-
tory granule suspensions, or aliquots of membranous or soluble components
from these lysates, were combined with a fraction ofthe prohormone prepara-
tion and sufficient 100 mM sodium acetate-acetic acid, pH 5.2, (or other buffer
when indicated) to bring the incubation volume to 1 ml. The membrane
protein/prohormone protein ratios in the incubates ranged between 1 :1 and
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incubation medium using narrow range (pH 3.0-5.5) pH paper. If necessary,
the pH was adjusted with either 2 M acetic acid or 2 M sodium acetate to be
as close to 5 .2 as possible. Incubations proceeded in capped siliconized glass
vials for 6 h at 30°C in a metabolic shaking incubator. At the end of the
incubation, 250 yl of 10 Macetic acid was added to bring the final acetic acid
concentration to 2 M. After a 30-min extraction period, insoluble material was
removed by centrifugation and reextracted with 0.5 ml of 2 M acetic acid. The
insoluble material wasagain removed andthe pooled supernatant was subjected
to gel filtration.
Assay of Products:
￿
Monitoring the accuracy of in vitro secretory
granule or microscme-mediated prohormone conversion was accomplished by
subjecting cleavage products recovered from gel filtration eluates to reverse-
phase HPLC. The HPLC system consisted of a Perkin-Elmer series 3B liquid
chromatograph (Perkin-Elmer Corp., Norwalk, CT) linked to a Perkin-Elmer
LC-75 spectrophotometer and a Perkin-Elmer Sigma 10 chromatography data
station. The columns employed were 0.46 x 25 cm Vydac C,g (300-t1 pore
size, 5-,um bead size; Separations Group; Hesperia, CA)columns end-capped
with Cz. Elution was accomplished by using a variable mixture of solutions A
and B. Solution A was 0.24% trifluoroacetic acid (40%) and CH,CN (60%).
Solution B was 0.I% trifuoroacetic acid. Acetonitrile concentrations during
gradient elution are shown on each figure. Prohormone cleavage products were
recovered from the Mr 4,500-8,000 (insulin), M r 2,500-4,500 (glucagon-related
peptides and SS-28), and the ßb7, 1,000-2,000 (SS-14) portions ofgel filtration
eluates, lyophilized, suspended in freshly prepared 3 M acetic acid, and filtered
through 0.22 pro filters (Millipore Corp., Bedford, MA) before injection for
HPLC. Accuracy ofproduct cleavage was monitored by comparing the HPLC
retention times of radiolabeled in vitro conversion products with those of
labeled products from tissue extracts and, in the case of SS-14, with synthetic
SS-l4. As it is known that even slight modifications in peptide structure can
significantly alter HPLC retention time (16), cleavage products generated in
vitro that had HPLC retention times identical tothoseoftissue extract products
were considered to be accurately cleaved. To compensate for slight variations
in retention timesof identifiable peptides which were observed periodically, a
tissue extract control sample was always run on the same day as any conversion
products to which its elution pattern was to be compared.
Protein Assay, Radioimmunoassay, and Thiamine Pyro-
phosphatase Assay:
￿
Protein was assayed according to the method of
Bradford (17) and somatostatin radioimmunoassay was performed as previ-
ously described (18) using the centrally directed R141 antiserum. Thiamine
pyrophosphatase was assayed by the method of Novikoff and Heuss (19) as
modified by Meldolesi et al. (20).
Electron Microscopy:
￿
Microsomal subtractions were sedimented by
centrifugation and fixed for 1.5 h at 4°C in 1.5% (vol/vol) glutaraldehyde in
0.1 M sodium phosphate buffer, pH 7.2. After postfixation in 2.0% (wt/vol)
OsO, in the same buffer, samples were dehydrated through a graded series of
ethanol and propylene oxide and embedded in Epon. Thin sections were cut,
mounted on Formvar-coated grids, stained with uranyl acetate and lead citrate,
and examined with a Philips 400 electron microscope (Philips Electronic
Instruments, Inc., Mahwah, NJ). Random photographs were taken of fields in
sections from the center, intermediate, and surface areas ofthe pellet from each
block.
RESULTS
Converting Activity of secretory Granules
All results shown in Figs. 1-7 are representative examples
of one from at least three experiments.
An example of the results from incubation of ['H]trypto-
phan and [ I"C]isoleucine-labeled prohormones with complete
secretory granule lysates is shown in Fig. 1. Depletion of the
prohormones of M, 8,000-15,000 and the appearance of
smaller 'H-labeled and 1"C-labeled peptides was observed.
This pattern of label elution corresponds precisely with the
patterns generated by gel filtration of extracts of pulse-incu-
bated islet tissue (1-3, 13). Products from granule lysate-
mediated conversions were recovered by pooling portions of
gel filtration eluates, as indicated by the bars under Fig. 1 B,
to be examined by HPLC. Fig. 2, A-C depicts the HPLC
elution pattern of labeled peptides of 111, 1,000-2,000 gener-
ated by incubation of prohormones with complete granule
lysate, granule lysate supernatant, and granule membranes,
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respectively. The results demonstrate that the major ['H]-
tryptophan-labeled product generated in all three types of in
vitro incubation has a retention time identical with that of
synthetic SS-14 (25 min). That this peptide was indeed so-
matostatin-related was determined by demonstrating that it
possesses somatostatinlike immunoreactivity (Fig. 2A). The
results in Fig. 2 indicate that both the soluble and membra-
nous components of islet secretory granules contain an en-
zyme(s) capable of accurately cleaving PSS-I to yield SS-14.
A second ['H]tryptophan-labeled peptide from the M,
1,000-2,000 pool eluted with a retention time (RT) of 14
min. This is the elution position of [Tyr7, Gly1°] SS-14 under
the conditions employed. These results indicate that either
PSS-II or AF SS-28 was cleaved to release [Tyr', Gly 1°] SS-14
in these in vitro incubations. This, however, does not repre-
sent accurate cleavage of PSS-II, because (Tyr7, Glyl°] SS-14
is not a normal cleavage product of PSS-II in the intact cell
(13, 14). The implications of this observation are considered
in the Discussion.
When the ['H]tryptophan plus ['4C]isoleucine doubly la-
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FIGURE 1
￿
Islet prohormone conversion mediated by lysed secre-
tory granules. [3H]tryptophan- and ['"C]isoleucine-labeled islet
polypeptides of M, = 8,000-15,000 (prohormones) were incubated
6 h in the absence or presence of a lysed secretory granule prepa-
ration. Granule lysate protein to substrate protein ratio was 4:1 .
Extracts were subjected to gel filtration as described in Materials
and Methods. Alternate 1 .5-ml fractions were assayed for radioac-
tivity. The distribution of 3H- (-) and "C- (-----) radioactivity in
the column eluates of the samples incubated in the absence and
presence of a granule lysate is shown in A and B, respectively.
Arrows in B indicate the elution positions of anglerfish insulin (AFI),
glucagon-related peptides, and somatostatin-28 (GISS-28), and so-
matostatin-14 (SS-14). The bars below B indicate regions of the
eluate recovered for HPLC analyses.
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FIGURE 2
￿
Action of granule and microcomal lysate components
on PSS-I . Secretory granules were prepared from 173 mg of tissue
and lysed. Two-thirds of the lysate was removed and separated into
soluble and membranous components by centrifugation. Labeled
prohormones of Mr = 8,000-15,000 were incubated 6 h with the
remaining complete granule lysate, the soluble fraction, or with
granule membranes. After gel filtration of the extracts, the peptides
of Mr = 1,000-2,000 were recovered (bar, Fig. 18) and aliquots
were taken for HPLC analyses. Fractions of 0.8 ml (1 .0 min) were
collected to assay for radioactivity (A-C). The elution protocol was
identical for each preparation (C) . (D) Microsomes prepared from
beled peptides of Mr 2,500-8,000 from tissue extracts were
analyzed by HPLC, 'H-labeled AF SS-28 (Noe, B., and J.
Spiess, manuscript in preparation) and ' 4C-labeled AF insulin
(2) were clearly identified as products (Fig. 3). Products of
proglucagon cleavage were also generated. All but one of the
'H-labeled peptides that appear in addition to SS-28 as eluate
peaks in Fig. 3A have been identified by RIA as glucagon-
related peptides (2 and unpublished results). Several of the
glucagon-related peptides (RT 43.5, 45 .5, and 47.0 min) were
observed after granule-mediated conversion (Fig. 3B), Thus,
the 'H labeling observed in the Mr 2,500-8,000 region of gel
filtration eluates (Fig. 1 B) represents a combination of ['H]-
tryptophan-labeled glucagon-related peptides and AF SS-28.
When the granule supernatant and membrane components
were examined separately for converting activity, it was found
that both mediated the generation of insulin and some glu-
cagon-related products; however, only the soluble component
generated appreciable SS-28 (Fig. 4).
If the granule membrane preparations were washed with 1
M KC1(a treatment known to promote dissociation of mem-
brane-associated proteins) before incubation, a significant
reduction of granule membrane-mediated conversion re-
sulted. KCl-washed membranes produced 69% less insulin,
55% less glucagon, and 47% less SS-14 than membranes
washed in sodium acetate buffer alone. This suggests that a
significant proportion ofthe enzyme(s) involved in converting
several of the islet prohormones to their respective products
is granule membrane-associated (Figs. 2 C and 4 C).
Converting Activity of Microsomes
Lysates of microsome fractions, when incubated with la-
beled prohormones at pH 5.2, were found to deplete the
prohormones and to generate products with labeling patterns
and molecular sizes similar to products derived from granule-
mediated conversion (Fig. 5). Results from previous work
have demonstrated that the pH optimum for in vitro conver-
sion mediated by granule components is near pH 5.0 (2). To
determine whether converting activity generated by microso-
mal components has a similar pH optimum, microsomal
lysates were incubated with labeled prohormones in buffers
at pH 5 .2 and 7 .5 as previously described (2). Microsome-
mediated prohormone conversion proceeded readily at pH
5.2. Incubation at pH 7.5 completely abolished microsome-
mediated conversion (data not shown). It has also been dem-
onstrated previously that cysteine proteinase inhibitors block
islet granule-mediated converting activity (1, 2). To determine
whether a cysteine proteinase inhibitor was effective in inhib-
iting conversion by microsomes as well, the sensitivity of
microsomal lysate-converting activity to p-chloromercuriben-
zoate was monitored. It was found that 100 MM p-chloro-
mercuribenzoatewas a very effective inhibitor ofprohormone
conversion (data not shown). Therefore, several characteristics
of converting-enzyme activity in microsomal lysates appear
58 mg of tissue were lysed and incubated with labeled prohor-
mones; the material of Mr = 1,000-2,000 from the resulting extract
was subjected to HPLC as in A-C. -,'H-radioactivity; -----, 14c_
radioactivity; stippled area, SS-14-like ímmunoreactivity; - - -, ace-
tonitrile gradient. The arrows indicate the elution position of syn-
thetic (and anglerfish) SS-14 and [Tyr' (Y, Gly'° (G)] SS-14 ([Y', G'°]
SS-14) under the conditions employed.
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FIGURE 3 Action of complete
granule lysate on proinsulin, proglu-
cagon(s), and PSS-II . Preparation of
secretory granules and incubation
with prohormones was as described
in Fig. 2 . (A) Distribution of 3H-
(,) and "C- (-----) radioactivity
in the eluate after HPLC of a small
portion of the combined peptides
of M, = 2,500-8,000 from several 5-
h pulse incubations of islets in the
presence of ['H]tryptophan and
['"C]isoleucine. (B) 'H- and '"C-ra-
dioactivity in the eluate after HPLC
of peptides of M, = 4,500-8,000
generated by incubation of labeled
prohormones with secretory gran-
ule lysate. (C) 'H- and '"C-radioac-
tivity in the eluate after HPLC of
peptides of M, = 2,500-4,500 gen-
erated from the same incubation as
in B. All runs were performed using
identical elution conditions. Frac-
tions of 0.4 ml (0.5 min) were col-
lected for assay of radioactivity.
. " ., acetonitrile gradient. Arrows
indicate the elution positions of an-
glerfish SS-28 and insulin (AF/).
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FIGURE 4
￿
Action of granule lysate membranous and
soluble components on proinsulin, proglucagon(s),
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membranes and soluble components were as de-
75 .2 b
￿
scribed in Fig. 2 . (A) Distribution of 'H- (-) and
"C- (-----) radioactivity in the eluate after HPLC of
56.4 w
￿
the peptides of M, = 2,500-8,000 from several tissue
' extracts as in Fig. 3A. B and C, the distribution of H-
and "C-radioactivity in the eluate after HPLC of
500-000 generated by incuba- 16.7 á
￿
peptides of M, = 2,8,0
￿
tion of radiolabeled prohormones Of Mr = 8,000
0.0
￿
15,000 with granule supernatant (B) and membranes
(C). Conditions for HPLC were the same in all runs.
84.0
￿
. . . ., acetonitrile gradient. Markers for the elution
positions of anglerfish SS-28 and insulin are as in
67 .2
￿
previous figures.6.5
5.2
3.9
2.6
0.0
SS-28
20 40 e0 80 100
FRACTION NUMBER
TISSUE EXTRACT CONTROL
Mr 2,.500-8,000
( AFI, G, SS-28 )
120
Mr 8,000-2,500
￿
Mr 2,000-1,000
FIGURE 5 Islet prohormone conversion mediated by lysed islet
microsomes. ['H]tryptophan- and [1°C]isoleucine-labeled prohor-
mones of Mr = 8,000-15,000 were incubated 6 h in the absence or
presence of lysed islet microsomes prepared from 58 mg tissue.
Microsomal lysate protein to substrate protein ratio was 1 :1 . The
resulting products were subjected to gel filtration and alternate 1 .5-
ml fractions were assayed for radioactivity. The distribution of 'H-
(-) and 1"C- (-----) radioactivity in column eluates derived from
running extracts of prohormones incubated in the absence (A) and
presence (B) of microsomal lysate is shown . Arrows indicate the
elution positions of anglerfish insulin (AFI), glucagon and SS-28 (G/
SS-28), and SS-14. The bars below B indicate regions of the eluate
recovered for HPLC analyses.
very similar to activity characterized previously in secretory
granule lysates (1, 2).
Differences between granule- and microsome-mediated
conversion were observed, however, when cleavage products
were analyzed by HPLC. The peptides ofMr 1,000-2,000 and
2,500-8,000 produced by in vitro incubation of microsomal
components with labeled prohormones were recovered from
the appropriate regions of gel filtration eluates (bars, Fig. 5 B).
It should be noted that the major 'H-labeled peptide(s) which
elutes in the M r 1,000-2,000 portion ofthe gel filtrationeluate
does not coelute with the SS-14 marker (Fig. 5B). When this
peptide pool was subjected to HPLC, it was found that no
'H-labeled peptide having the RT of SS-14 was present (Fig.
2D). In contrast to secretory granule lysates, microsomal
lysates were incapable of mediating the correct processing of
PSS-1. However, when the peptides of Mr 2,500-8,000 gen-
erated by incubation with microsomal components were ex-
amined by HPLC, several conversion products were readily
identified (Fig. 6). It is evident that AF SS-28, AF insulin,
and at leasttwo glucagon-related products (RT 43.0 and 45.0)
were generated by microsomal lysates. When the converting
activities of microsomal membranes and soluble components
were assayed separately, it was found that most of the proglu-
cagon-to-glucagon and PSS-II-to-SS-28 converting activity
was present in the soluble fraction (Fig. 7). However, the
proinsulin-to-insulin converting activity of the soluble frac-
tion was only slightly greater than that of the membranous
fraction.
Relative Contribution of Golgi Complex and RER
to Microsomal Converting Activity
To ascertain whether there was a difference in the relative
contribution of Golgi components and elements of the en-
doplasmic reticulum to the overall converting activity of
microsomes, Golgi complex and RER-enriched subfractions
of microsomes were prepared and tested for the ability to
convert islet prohormones. The subfractions generated were
characterized by assay for thiamine pyrophosphatase (Golgi
marker) (21) and electron microscopic examination . The data
in Table I demonstrate that the uppermost bands recovered
from the sucrose gradient (subfractions 1 and 2) had the
A
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7.2
4.8
2.4
0.0
61.0
48.8
36.6
24.4
12.2
0.0
FIGURE 6 Action of complete mi-
crosomal lysate on proinsulin, pro-
glucagon(s), and PSS-II . (A) HPLC of
tissue extract peptides of Mr =
2,500-8,000 as in Figs. 3A and 4A.
(B) Distribution of 'H- (-) and
1°C- (-----) radioactivity in the eluate
after HPLC of peptides of Mr =
2,500-8,000 (bar, Fig. 5B) gener-
ated by incubation of labeled pro-
hormones with lysed microsomes
prepared from 50 mg of tissue.
Identical elution conditions were
used in both runs. - - - -, acetonitrile
gradient; other markers are as in
previous figures.
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SS-28
highest Golgi membrane content, and that RER predominates
in subfractions 4 and 5 . Conversion assays were performed
using subfractions 1-4 only; insufficient material was re-
covered from subfraction 5. The data in Table II document
the results from these conversion assays. Data for SS-14
production are not included as microsome fractions were
found to be incapable of accurately cleaving PSS-I to yield
SS-14 (Figs. 5 and 2D). The results do demonstrate, however,
that the microsomal subfractions were capable of mediating
the generation of cleavage products having the labeling and
molecular size characteristics ofinsulin, glucagon-related pep-
tides, and SS-28. To determine whether the peptides generated
by incubation of prohormones with microsomal subfractions
could be identified as prohormone cleavage products, the
peptides of Mr 2,500-8,000 produced by all four subfractions
in a single experiment were pooled for HPLC analysis. The
HPLC results demonstrated that SS-28, insulin, and several
of the glucagon-related products were present in this pool of
products (data not shown). Given that the converting activity
of the microsomal subfractions generates accurately cleaved
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Comparison of the actions of soluble and membranous components of microsomes on proinsulin, proglucagon(s), and
PSS-II . (A) HPLC of tissue extract peptides of Mr = 2,500-8,000 as in Figs. 3A, 4A, and 6A. Microsomes prepared from 121 mg
of tissue were lysed and separated into membranous and soluble components by centrifugation. Each component was incubated
separately for 6 h with prohormones labeled with [3Hltryptophan and ['°Clisoleucine. (B and C) Distribution of 3 H- (-) and
'°C- (-----) radioactivity in the eluates after HPLC of the peptides of Mr = 2,500-8,000 generated by incubations with soluble
components (B) and membranes (C) from microsomes. - - - -, acetonitrile gradient; other markers are as in previous figures.
products, it is noteworthythat all subfractions produced prod-
ucts, and that there was no significant difference in the
amount of products generated by any one of the subfractions
as compared to the others (Table Il).
The results from experiments using complete secretory gran-
ule lysates demonstrate that these lysates mediate the accurate
conversion of PSS-I to SS-14, PSS-II to SS-28, and proinsulin
to insulin (Figs. 1-3). The observation that nearly all of the
peptides generated during these conversion assays could be
identified as accurate cleavage products suggests that nonspe-
cific proteolysis is negligible in the assay system. Several
glucagon-related peptides that are consistently found in tissue
extracts were also generated by converting activity in secretory
granule lysates (Figs. 1 and 3). These data confirm and extend
our previous results (1, 2). In our earlier studies on the
processing of PSS-I, conversion products generated by granule
lysates were identified by gel electrophoresis (1). Using re-
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UTABLE I
Analyses of Microsomal 5ubfractions
Microsomal subfractions were prepared, concentrated, and resuspended as
described in Materials and Methods. Aliquots were removed for the thiamine
pyrophosphatase assay, and portions of the remainderwere fixed for electron
microscopic analysis. Thiamine pyrophosphatase results are expressed as
percent of total activity (micromoles of POa/milligram subfraction protein)
recovered from each set of subfractions (mean ± standard error for the
number of determinations in parentheses). For the electron microscopic
analysis, six representative micrographs of the contents of each fraction were
analyzed for the presence of smooth and rough membranes. The perimeters
(in micromoles) of all vesicles that could be clearly identified as being either
smooth or ribosome-studded were traced on a graphics-digitizing pad linked
to a minicomputer. Data are expressed as the sum of all perimeters in each
class.
TABLE II
Comparison of the Prohormone-converting Activity of
Microsomal 5ubfractions
Microsomal subfractions were recovered from discontinuous sucrose gra-
dients, then concentrated, suspended, and lysed as described in Materials
and Methods. Lysates were incubated 6 h at 30°C with labeled prohormones
at a microsome protein to prohormone ratio of 2:1 . Extracts were subjected
to gel filtration and percent product was determined as previously described
(2, 3). Data represent mean (± standard error) for the number of determina-
tions shown in parentheses. Analyses of these data with both t-test and
ANOVAmethods revealed no significant differences between the converting
activity of the subfractions.
verse-phase HPLC, a more resolutive technique, we have now
demonstrated that the major ['H]tryptophan-labeled product
with a molecular size between 1,000 and 2,000 has a RT
identical to that of synthetic SS-14 (Fig. 2). It was of interest
to find that a second 'H-labeled peptide having the RT of
synthetic [Tyr', Gly'°] SS-14 was also generated (Fig. 2, A-
C). The generation of this peptide is considered to be an
artifact ofthe in vitro conversionsystem because [Tyr', Gly'°]
SS-14 cannot be identified in extracts of AF islet tissue (13,
14). As secretory granules from all islet cell types were present
in these assays, the PSS-I to SS-14 converting enzyme would
have access to PSS-II, and could cleave [Tyr', Gly'°] SS-14
from PSS-II or AF SS-28 . If PSS-I and PSS-II are produced
in different cell types, as discussed later, then it would be
unlikely for this cleavage to occur either in vivo, or in intact
tissue incubated in vitro.
Additional information regarding granule-mediated con-
version of proglucagons was also obtained. It is evident that
more glucagon-related peptides were observed after incuba-
tion of prohormones with secretory granule lysates (Figs. 3
and 4) than in a previous study (2). This can be attributed to
longer incubation times (6 h in the present study vs. 4 h
previously), and the use of HPLC columns that are more
highly resolutive and provide much better recoveries oflarger
peptides. Further analysis of the proglucagon-converting ac-
tivities ofislet microsomes and secretory granules must await
identification and characterization of the glucagon-related
peptides generated in intact tissue and during in vitro conver-
sion assays.
The primary purpose of the present study was to perform
a thorough examination of prohormone converting activity
in islet microsomes and microsomal subfractions and to com-
pare microsomal converting activity with that in secretory
granules. Results from previous studies indicated that, during
in vitro incubations, islet microsomes have the ability to
deplete labeled prohormones and generate products having
molecular size and labeling characteristics of islet hormones
(1, 2, 22). However, this microsomal converting activity had
never been thoroughly characterized. As indicated in Results,
the converting enzymes in microsomes are similar to those in
granules with regard to pH optimum and susceptibility to
inhibition by a cysteine proteinase inhibitor. When the prod-
ucts of conversion mediated by microsomal lysates were
analyzed by HPLC and compared to products derived from
granule mediated conversion, both similarities and differences
were observed.
Microsomal lysates exhibited converting activity for PSS-II
and proinsulin (Figs. 6 and 7), but, unlike secretory granule
lysates (Fig. 2, A-C), were incapable of cleaving significant
amounts of SS-14 from PSS-I (Fig. 2D). A significant propor-
tion ofthe proinsulin and PSS-II converting activity in micro-
soma] lysates was associated with the membranous compo-
nent (Fig. 7 C). All ofthe monitored prohormone-converting
activities, except that for PS-II to SS-28 conversion, appear to
be membrane-associated to some extent in both microsomes
and secretory granules (Figs. 2C, 4 C, and 7 C). The converting
activity of PSS-II was found to have no apparent membrane
association in secretory granules (Fig. 4C). No attempt to
compare relative specific converting activities in the mem-
brane-associated vs. soluble fractions of either microsomes or
secretory granules was made. Such comparisons would be
inaccurate because of differential dissociation of enzymes
from membranes during freeze-thaw lysis.
Membrane association of prohormone-converting en-
zyme(s) has also been demonstrated in secretory granules
from rat anterior pituitary (10) and neurointermediate lobe
(23) as well as in rat hypothalamic synaptosomes (24). Al-
though the significance of membrane association of convert-
ing enzymes has not been investigated thoroughly, there is
some evidence that newly synthesized prohormones may be
granule membrane-associated as well (25, 26). We have re-
cently obtained data which indicates that newly synthesized
islet prohormones are microsome and secretory granule mem-
brane-associated. If this proves to be a general phenomenon,
then it would seem reasonable to propose that association of
converting enzymes with RER/Golgi complex and secretory
granule membranes may facilitate maintenance ofjuxtaposi-
tion between enzyme and substrate.
Analysis ofconverting activity in Golgi complex- and RER-
enriched subfractions of microsomes demonstrated that ac-
curate cleavage products were produced by the subfractions,
and that there was no significant difference in converting
activity between the various subfractions (Table II). It is thus
evident that both RER and Golgi elements contain converting
enzymes. These results are consistent with the hypothesis
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Thiamine
pyrophosphatase
Electron microscopic analysis
Sub-
fraction Total recovered
%
Smooth
membranes
Rough
membranes
'Um
1 31 .6 ± 4.4 (4) 4,119.4 843.8
2 27.5 ± 4.0 (4) 4,402 .4 1,358.6
3 19.2 ± 0.8 (4) 2,198.3 1,484.7
4 13.1 ± 0.8 (4) 1,560.0 3,739.5
5 8.6 ± 1 .7 (4) 696.8 2,458.7
Subfraction
1 (Golgi complex rich)
Product
Insulin
96
16.1 ± 1 .3 (4)
Glucagon/SS-28
%
11 .4 ± 2 .7 (4)
2 16.5±2 .5(4) 10.5±1 .6(4)
3 22.8 ± 1 .7 (4) 13.6 ± 2 .5 (4)
4 (RER rich) 22.0 ± 4.0 (4) 13.7 ± 2 .6 (4)proposed previously (2) that the converting enzymes may be
synthesized at the RER along with the prohormones, then
transferred into the RER cisternae, and transported along
with the newly synthesized hormone precursors to the Golgi
apparatus and secretory granules. However, the demonstra-
tion of converting activity in the RER and Golgi components
does not necessarily imply that a significant proportion of
overall converting activity occurs in these organelles in vivo.
The in vitro assays in which conversion was observed were
performed at pH 5 .2. If the intracisternal pH ofthe RER and/
or Golgi complex in the intact cells is near pH 7 or above,
then it is unlikely that the converting enzymes would be very
active in vivo. Moreover, it is possible that converting en-
zyme(s) destined to mediate processing in secretory granules
may be less active when present in RER and Golgi complex
due to conformational or structural constraints that impede
expression of full activity. This could be exemplified by the
converting enzyme(s) of PSS-I in AF islet, which was found
to be active only in secretory granules. Because in vitro
measurements of microsomal converting activity may not
accurately reflect the situation in the intact cell, no attempt
to compare relative specific converting activities in micro-
somes and secretory granules was made.
The data comparing the types and distribution of micro-
some and secretory granule converting activities does, how-
ever, provide new information regarding the mechanism of
differential processing of PSS-I and PSS-II. When the results
from both secretory granule- and microsome-mediated con-
version of these precursors are considered, the clear implica-
tion is that (at least) two separate enzymes which have differ-
ential distribution or activity are involved. The converting
enzyme of PSS-I is active and membrane-associated in secre-
tory granules. The fact that this processing activity was not
observed in microsomes implies that the converting enzyme
for PSS-I is either not present or is inactive in RER and Golgi.
If all converting enzymes are synthesized along with hormone
precursors at the RER as proposed above, then it is probable
that the PSS-1-processing enzyme is present, but inactive, in
microsomes. The PSS-II-converting enzyme was active in
both microsomes and secretory granules but was found to be
membrane-associated only in microsomes. Other observa-
tions are also consistent with the proposal that two different
enzymes may be involved in processing PSS-I and PSS-II.
The PSS-I cleavage site is on the carboxyl side of an Arg-Lys
sequence at positions -1 and -2 in PSS-I (27, 28), whereas
the PSS-II cleavage site is on the carboxyl side of a single Arg
at position -15 in PSS-II (27 ; manuscript in preparation).
Moreover, preliminary results using immunohistochemical
methodology indicate that PSS-I and PSS-II are synthesized
in separate cells (Noe, B. D., and G. E. Bauer, unpublished
data).
The differential subcellular distribution of converting activ-
ity of PSS-I and PSS-II would allow, under appropriate con-
ditions, conversion of PSS-II to begin early during the trans-
port process (i.e., in the rough endoplasmic reticulum and/or
Golgi complex) whereas the predominant PSS-I processing
would occur distally in the secretory granules. A somewhat
analogous situation has been described in the rat pituitary
intermediate lobe by Glembotski (29), who demonstrated that
processing of pro-opiomelanocortin to release ß-lipotropin
occurred in the microsomes, whereas most of the conversion
of ß-lipotropin into ß-endorphin-sized peptides occurred in
secretory granules. Finally, the results of the present study
may be relevant to the differential processing of prosomato-
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statin which occurs in mammals. Results from numerous
studies have demonstrated differential distribution of both
SS-28 and SS-14 in various tissues (30-33), and release of
both peptides into plasma (33-36). It is probable that the
amount of either peptide that is produced in various tissues
depends on differential cleavage of prosomatostatin. To de-
termine whether the mechanism in mammals involves two
separate enzymes, as is apparent in fish islets, will require
additional investigation in mammalian systems.
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